Your browser doesn't support javascript.
loading
First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia.
Rea, D; Etienne, G; Nicolini, F; Cony-Makhoul, P; Johnson-Ansah, H; Legros, L; Huguet, F; Tulliez, M; Gardembas, M; Bouabdallah, K; Rousselot, P; Cayuela, J-M; Guilhot, F; Mahon, F-X.
Affiliation
  • Rea D; Service des Maladies du Sang et EA3518, Hôpital Saint-Louis, Paris, France. delphine.rea@sls.aphp.fr
Leukemia ; 26(10): 2254-9, 2012 Oct.
Article in En | MEDLINE | ID: mdl-22460758
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myeloid, Accelerated Phase / Fusion Proteins, bcr-abl / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2012 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myeloid, Accelerated Phase / Fusion Proteins, bcr-abl / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2012 Document type: Article Affiliation country: